Common Stock, $0.01 par value per share
- Symbol
- HCA
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 7.01, 9.01 · 8-K
HCA Healthcare, Inc.
HCANYSEEQUITYCurrent
Results of Operations and Financial Condition · Regulation FD Disclosure
Item 2.02. Results of Operations and Financial Condition. On July 14, 2026, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its preliminary results of operations for the second quarter ended June 30, 2026, the text of which is set forth as Exhibit 99.1.
Press release in this filing
HCA Healthcare PREVIEWS SECOND quarter 2026 results REVISES 2026 GUIDANCE →Company context
Nashville-based HCA Healthcare is one of the nation’s leading providers of healthcare services comprising 192 hospitals and approximately 2,500 ambulatory sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics, in 20 states and the United Kingdom. With its founding in 1968, HCA Healthcare created a new model for hospital care in the United States, using combined resources to strengthen hospitals, deliver patient-focused care and improve the practice of medicine. HCA Healthcare has conducted a number of clinical studies,
Current securities
Recent company filings
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Other EventsNov 5, 2026
- FWP - filed by HCA Healthcare, Inc. regarding HCA Healthcare, Inc.Nov 3, 2026
- Other EventsNov 2, 2026
- 10-Q filingOct 29, 2026
- Results of Operations and Financial Condition · Regulation FD Disclosure · Other EventsOct 27, 2026
Registered securities in this filing
HCA Healthcare, Inc. · 8-K · Filed 2026-07-14
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition.
On July 14, 2026, HCA Healthcare, Inc. (the “Company”) issued a press release announcing, among other matters, its preliminary results of operations for the second quarter ended June 30, 2026, the text of which is set forth as Exhibit 99.1.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure.
On July 14, 2026, the Company issued a press release announcing, among other matters, its preliminary results of operations for the second quarter ended June 30, 2026, the text of which is set forth as Exhibit 99.1.
Filed exhibits (1)
EX-99.1 2 hca-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare PREVIEWS SECOND quarter 2026 results REVISES 2026 GUIDANCE Nashville, Tenn., July 14, 2026 - HCA Healthcare, Inc. (NYSE: HCA) today announced preliminary financial and operating results for the second quarter ended June 30, 2026. The preliminary financial and operating results are subject to finalization of the Company's quarterly financial and accounting procedures. HCA anticipates revenues in the second quarter of 2026 to approximate $20.230 billion, compared to $18.605 billion in the second quarter of 2025. Net income attributable to HCA Healthcare, Inc. is expected to approximate $1.699 billion, or $7.62 per diluted share, compared to $1.653 billion, or $6.83 per diluted share, in the second quarter of 2025. Results for the second quarter of 2026 include anticipated gains on sales of facilities of $10 million, or $0.03 per diluted share. Results for the second quarter of 2025 included losses on sales of facilities of $3 million, or $0.01 per diluted share. Fo…
Open exhibit ↗